Researchers conduct deep brain stimulation in Alzheimer's patient
(Medical Xpress)—Researchers at the University of Florida have performed deep brain stimulation on a patient with Alzheimer's disease as part of a clinical trial studying whether the treatment can slow progression of the disease.
Called the Advance Study, the multicenter clinical trial will evaluate whether using electrodes to stimulate a part of the brain called the fornix can slow memory decline and improve cognitive function in patients in the early stages of Alzheimer's disease. The trial is taking place at four sites across the United States, including UF.
"The goal of treating Alzheimer's disease with neuromodulation is to try to enhance what patients have and slow down memory loss and the process of the disease so they can have a few more years of good function," said Dr. Michael Okun, co-director of the UF Center for Movement Disorders and Neurorestoration and a site principal investigator for the study. "This is a potentially exciting symptomatic therapy."
This video is not supported by your browser at this time.Deep brain stimulation is used to treat a variety of conditions, including Parkinson's disease, dystonia and Tourette syndrome. In the procedure, researchers carefully place electrodes in specific regions of the brain. When these electrodes are turned on, they send electrical signals that prompt a therapeutic response.
"In Alzheimer's patients there is a very slow loss of brain function," Okun said. "These slow changes that happen in the brain lead to the clinical symptoms. The idea is that we are going to try and modulate the circuits to see if we can improve some of the symptoms."
Researchers decided to test deep brain stimulation in the fornix—a part of the brain that connects the hippocampus to the hypothalamus—after the accidental discovery that stimulating that region of the brain provoked vivid memories in patients, Okun said.
The therapy is being tested at four sites: UF, Toronto Western Hospital, the Banner Alzheimer's Institute and Johns Hopkins University. Overall, 20 patients will be enrolled in the trial, although the electrodes will not be turned on in all the participants, Okun said.
"This is the best way for us to tell if there is a real response versus a placebo response," he said. "It's very tricky to measure memory and cognition."
Aside from testing the effectiveness of the therapy, researchers also are closely examining how stimulating the brain affects the course of Alzheimer's disease and whether it prompts changes in oxygen, in glucose levels and in blood flow.
"What we have seen so far is there are very interesting changes in blood flow," Okun said. "It's very early and it is hard to judge these things just on pictures but the pictures look very interesting. There is definitely something going on in the circuit."
Provided by University of Florida
- In US first, Johns Hopkins surgeons implant brain 'pacemaker' for Alzheimer's disease Dec 05, 2012 | not rated yet | 0
- Deep Brain Stimulation shows promise for patients with Alzheimer's Aug 04, 2010 | not rated yet | 0
- Ohio State implants first brain pacemaker to treat Alzheimer's Jan 23, 2013 | not rated yet | 0
- Researchers study mitochondrial function, potential new therapeutic target for Alzheimer's disease Feb 15, 2012 | not rated yet | 0
- Deep brain stimulation may hold promise for mild Alzheimer's disease May 07, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Calculating on-axis elements of a solenoid
1 hour ago I'm doing research with a professor and I'm tasked with calculating the magnetic field produced by a solenoid. I have the measured values from the...
latitude & longitude & air pressure
2 hours ago Hi there, I have a peculiar question. Imagine that you are in a earth position, obtained by google, that gives you the latitude and longitude....
Differences of Classical Mechanics when learned with Calc vs algebra?
6 hours ago what are the differences? Every example I find usually has a derivative or integral or some kind of calculus defined concept that seems to make it...
what is the distance traveled
10 hours ago Hi. I have newly started to study mechanical physics. based on study, I conduct a simple experiment. But unfortunately i am unable apply the laws in...
Image of a Convex Lens Cut in Half Horizontally
13 hours ago Hello everyone, A friend of mine came up with this question in class and I really do not have a good answer. Suppose you have a convex lens...
Ray tracing throught optical system of thick lenses
14 hours ago Can you advise me a free software that allow to draw rays passed throught system of thick lenses (preferable in 3D)?
- More from Physics Forums - Classical Physics
More news stories
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
Alzheimer's disease & dementia May 21, 2013 | 5 / 5 (7) | 0 |
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
Alzheimer's disease & dementia May 20, 2013 | 5 / 5 (4) | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
Alzheimer's disease & dementia May 19, 2013 | 5 / 5 (3) | 0 |
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
Alzheimer's disease & dementia May 19, 2013 | not rated yet | 0
(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...
Alzheimer's disease & dementia May 17, 2013 | 5 / 5 (2) | 0 |
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
9 hours ago | 4.8 / 5 (5) | 0 |
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
9 hours ago | 4 / 5 (1) | 0 |
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
6 hours ago | 5 / 5 (2) | 2 |
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
6 hours ago | 5 / 5 (1) | 0 |
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
6 hours ago | not rated yet | 0 |
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...
8 hours ago | 5 / 5 (1) | 0 |